Cargando…
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
Mutational analysis of circulating tumour (ct) DNA holds promise as an effective tool to predict the course of metastatic breast cancer (MBC). In the present study we used targeted next generation sequencing of ctDNA to evaluate the impact of cancer driven mutations on the prognosis of MBC. The stud...
Autores principales: | Muendlein, Axel, Geiger, Kathrin, Gaenger, Stella, Dechow, Tobias, Nonnenbroich, Christoph, Leiherer, Andreas, Drexel, Heinz, Gaumann, Andreas, Jagla, Wolfgang, Winder, Thomas, Mayer, Frank, Decker, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990915/ https://www.ncbi.nlm.nih.gov/pubmed/33762647 http://dx.doi.org/10.1038/s41598-021-86238-7 |
Ejemplares similares
-
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients
por: Muendlein, Axel, et al.
Publicado: (2022) -
Hypoxia induces a HIF-1α dependent signaling cascade to make a complex metabolic switch in SGBS-adipocytes()
por: Leiherer, Andreas, et al.
Publicado: (2014) -
Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2022) -
Evaluation of the association of serum glypican-4 with prevalent and future kidney function
por: Muendlein, Axel, et al.
Publicado: (2022) -
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease
por: Leiherer, Andreas, et al.
Publicado: (2023)